glp-1 and stomach pain Intolerance Endoscopic Sleeve Options Common GLP-1 Weight-loss Side Effects

Therapy with GLP-1RA should therefore start with low doses that can be uptitrated ( GLP-1RA has been placed prominently in the international recommendations for the treatment of T2D as the first injectable agent before insulin due to the advantageous outcomes in cardiovascular safety studies that demonstrated a reduction of the combined cardiovascular endpoint three-component major adverse cardiovascular event (MACE-3

The disease is not genetically acquired, and the depigmentation occurs only when there is a persistent exposure or contact with the causative agent

When increased urination occurs, it typically reflects indirect factors such as improved blood glucose control, dietary changes, increased fluid intake, or co-prescribed medications like SGLT2 inhibitors or diuretics

Gastrointestinal symptoms that grow worse rather than easing up the longer youre on the drug

Retrieved from Yin, J., Ye, J., & Jia, W